Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase P1-1 (GSTP1-1) is a phase II detoxification enzyme that catalyzes the conjugation of glutathione to various hydrophobic and electrophilic compounds, playing a critical role in cellular defense against oxidative stress and toxic insults. It is a homodimer with two subunits, each containing a glutathione-binding site (G-site) and a hydrophobic substrate-binding site (H-site). Genetic polymorphisms, particularly at residue 105, affect substrate specificity and stability. GSTP1-1 is overexpressed in various cancers, contributing to drug resistance. Inhibitors are being developed to overcome chemoresistance in cancer therapies.
Inhibition of glutathione conjugation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase P1-1 (GSTP1-1).